Pages that link to "Q34109273"

The following pages link to Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica (Q34109273):

Displaying 20 items.

• Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells (Q33521195) (← links)
• Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine (Q34534842) (← links)
• Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes (Q35022961) (← links)
• Pharmacotherapy of iron overload in thalassaemic patients (Q35548173) (← links)
• An expedient reverse-phase high-performance chromatography (RP-HPLC) based method for high-throughput analysis of deferoxamine and ferrioxamine in urine. (Q36098167) (← links)
• Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics (Q36227416) (← links)
• The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management (Q36477489) (← links)
• Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance (Q36926651) (← links)
• Chronic Iron Overload Results in Impaired Bacterial Killing of THP-1 Derived Macrophage through the Inhibition of Lysosomal Acidification (Q36951328) (← links)
• Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (Q37229481) (← links)
• Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management (Q37854465) (← links)
• Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis. (Q38826753) (← links)
• Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients. (Q38937817) (← links)
• Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. (Q39488378) (← links)
• Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis (Q40068066) (← links)
• Effect of iron-chelator deferiprone on the in vitro growth of staphylococci (Q41832262) (← links)
• Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients (Q46987213) (← links)
• Cyclic AMP-receptor protein activates aerobactin receptor IutA expression in Vibrio vulnificus. (Q54337689) (← links)
• DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity (Q60410477) (← links)
• Vibrio vulnificus infection: a persistent threat to public health (Q89092065) (← links)